Investment Rating - The report initiates coverage on Lin Qingxuan with a "Buy" rating and a target price of HKD 130.88, corresponding to a 2026 adjusted PE of 28x [6][11]. Core Insights - Lin Qingxuan focuses on high-end anti-wrinkle and firming products, pioneering the "oil-based skincare" concept. The brand has a clear positioning and product category mindset, with significant growth potential in its market segment [6][10]. - The company has developed its flagship product, Camellia Oil, into its fifth generation, and its "1+4" product strategy includes a diverse range of products such as lotions, toners, creams, serums, and sunscreens, which are expected to drive future growth [6][8]. - Lin Qingxuan's omnichannel sales network supports steady growth in both online and offline sales, with strong R&D capabilities expected to reinforce its market leadership in niche segments and enable product innovation [6][9]. Financial Projections - Revenue projections for Lin Qingxuan are as follows: - 2024: RMB 1,210 million (+50.27%) - 2025: RMB 2,218 million (+83.34%) - 2026: RMB 3,214 million (+44.91%) - 2027: RMB 4,464 million (+38.91%) [5][11]. - Adjusted net profit forecasts are: - 2024: RMB 200.24 million (+126.37%) - 2025: RMB 385.40 million (+92.47%) - 2026: RMB 589.34 million (+52.92%) - 2027: RMB 821.16 million (+39.33%) [5][11]. - The adjusted net profit margin is expected to be 11.0% in 2023 and 16.6% in 2024, indicating improved operational efficiency [10][24]. Market Dynamics - The "oil-based skincare" market is currently experiencing rapid penetration growth, driven by product innovation, increased brand investment in product education, and a shift in consumer awareness towards skin barrier repair [7][21]. - Lin Qingxuan has established a strong brand identity around the Camellia flower ingredient, which has become synonymous with its product offerings, enhancing consumer recognition and loyalty [8][22]. - The company has a robust offline presence with 554 stores as of the first half of 2025, and it is actively expanding its online sales channels, leveraging live streaming and collaborations with KOLs to capture growth opportunities [9][22]. Competitive Positioning - Lin Qingxuan's ability to incubate successful single products and replicate this success across categories positions it favorably within the high-end skincare market, which is relatively concentrated [10][17]. - The company’s focus on high-quality raw materials and integrated supply chain management is expected to solidify its leadership in niche markets [23][24].

Core Insights - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, marking the emergence of the "first domestic high-end skincare stock" in China, indicating a significant shift in the high-end skincare market traditionally dominated by international brands [1][4] - The company aims to enhance its investment in dermatology, botany, and cutting-edge skincare technology while expanding brand building and retail store layout to create exceptional skincare experiences for customers and higher value for shareholders [1] Group 1: Product and Market Performance - Lin Qingxuan's flagship product, Camellia Oil, has established itself as a dominant force in the market, being the only domestic brand among the top 15 high-end skincare brands in China by retail sales in 2024 [5] - The Camellia Oil has maintained its position as the best-selling facial oil in China for 11 consecutive years, with cumulative sales exceeding 45 million bottles by June 30, 2025 [5][6] - The introduction of the new 5.0 Camellia Anti-Wrinkle Repair Oil is expected to further enhance sales performance, with clinical tests showing significant improvements in skin texture and appearance [6][7] Group 2: Financial Growth - Lin Qingxuan's revenue and profit have shown robust growth, with a 93% year-on-year increase in revenue to 1.052 billion yuan and a 120% surge in net profit to 182 million yuan in the first half of 2025 [7] - The contribution of the Camellia Oil category to total revenue is projected to rise from 31.5% in 2022 to 45.5% in the first half of 2025, indicating a clear upward trend [7] Group 3: Future Growth Strategies - Lin Qingxuan is focusing on three new growth strategies: expanding its flagship product matrix, building a multi-brand ecosystem, and exploring global markets [8] - The company plans to launch innovative products like the "Cell Energy Black Gold Cream 2.0" and expand the application of its core ingredients into new beauty and whitening product lines [8] - Lin Qingxuan has initiated its global expansion through Southeast Asia and cross-border e-commerce, creating new market opportunities [9] Group 4: Strategic Partnerships - The company has gained a significant indirect shareholder in L'Oréal, which is expected to enhance Lin Qingxuan's growth strategies by providing access to top-tier research resources and raw material procurement systems [10][11] - L'Oréal's expertise may support Lin Qingxuan's multi-brand strategy and internationalization efforts, ensuring a more stable and far-reaching growth trajectory [11] Group 5: Overall Outlook - The listing is viewed as a new starting point for Lin Qingxuan, with expectations for continued value creation and surprises in the future [12]

Core Viewpoint - Lin Qingxuan, a high-end domestic skincare brand, officially listed on the Hong Kong Stock Exchange on December 30, 2025, with a closing price of HKD 85 per share, a 9.3% increase from the issue price of HKD 77.77, resulting in a market capitalization of approximately HKD 11.9 billion [2][28]. Group 1: Company Overview - Lin Qingxuan's flagship product, the Camellia Oil, has sold over 45 million bottles since its launch in 2014, averaging 4.29 million bottles sold annually [8][28]. - The company has a diverse product line with 188 SKUs, including essential oils, creams, toners, lotions, serums, masks, and sunscreens, with essential oils, creams, serums, and sunscreens being the four core categories [5][32]. - The pricing of Lin Qingxuan's products ranges from 80 to 2000 RMB, with the 50ml Camellia Oil priced at 799 RMB and a New Year gift set priced at 1443 RMB [7][34]. Group 2: Financial Performance - From 2022 to 2024, Lin Qingxuan's revenue grew from 691 million RMB to 1.21 billion RMB, with a compound annual growth rate of 32.5%. In the first half of 2025, the company achieved revenue of 1.052 billion RMB and a net profit of 182 million RMB [8][35]. - The gross margin of Lin Qingxuan has been increasing, reaching 82.5% in 2024, with the gross margin for the Camellia Oil at 86.2%, comparable to high-end liquor margins [10][38]. - The marketing expenses over three and a half years totaled approximately 1.121 billion RMB, with a significant portion of the workforce (85.2%) dedicated to sales and marketing [11][12][39]. Group 3: Marketing Strategy - The founders, Sun Laichun and Sun Fuchun, actively engage in live streaming and social media to promote the brand, creating a unique "Lin Qingxuan family IP matrix" that includes family members participating in content creation [4][30]. - The company has accumulated around 7.96 million followers on Tmall and over 1.66 million on Douyin, with significant sales during promotional events [19][46]. - Lin Qingxuan has faced challenges with advertising compliance, receiving fines for misleading claims about product efficacy, which highlights the importance of regulatory adherence in marketing strategies [20][47]. Group 4: Market Position - Lin Qingxuan ranks first among all high-end domestic skincare brands in China and is the only domestic brand among the top 15 high-end skincare brands, including international competitors [8][34]. - The company has expanded its offline presence, with 554 stores nationwide, primarily located in shopping centers, reinforcing its high-end brand image [19][46]. - Despite facing consumer complaints regarding product efficacy and pricing, the overall market sentiment towards Lin Qingxuan remains positive, with significant backing from institutional investors [27][51].

Group 1 - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, with a stock code of 02657.HK, opening at HKD 85 after an IPO price of HKD 77.77, reaching a market capitalization of HKD 12.35 billion on the first day [1] - The company generated significant revenue from its core product, camellia oil, which accounted for nearly 40% of total revenue, with projections indicating it will contribute 45.5% of revenue by the first half of 2025 [1] - Lin Qingxuan's revenue for the first half of 2025 is projected to be HKD 1.052 billion, a substantial increase of 98% year-on-year, with net profit expected to rise by 110.16% to HKD 182 million [1] Group 2 - The IPO raised approximately HKD 997 million, primarily for R&D in skincare technology, brand building, and retail expansion [2] - Notable institutional investors, including Fidelity and Dajia Life, subscribed for about USD 62 million, representing 44.43% of the total shares offered [2] - L'Oréal Group has indirectly become a shareholder in Lin Qingxuan through Shanghai Kaihui Chuangmei, highlighting the brand's significance in the high-end skincare market [3] Group 3 - The listing process took about seven months from the initial filing to the final listing, marking a new phase for Lin Qingxuan in its multi-brand and global expansion strategy [4] - The trend of Chinese beauty brands seeking capital through Hong Kong listings is growing, with other brands like Chando and Proya also filing for IPOs [4]

Core Viewpoint - Lin Qingxuan Cosmetics Group officially listed on the Hong Kong Stock Exchange on December 30, 2025, with a strong IPO performance, raising approximately HKD 997 million for R&D, channel expansion, and brand upgrades [2][3] Group 1: Company Overview - Lin Qingxuan was founded in 2003 and has established a unique position in the Chinese skincare market with its "oil-based skincare" philosophy [2] - The company's core product, Camellia Oil Essence, has been the top-selling facial oil in China since its launch in 2014, with cumulative sales exceeding 50 million bottles [2][3] Group 2: Financial Performance - In the first half of 2025, Lin Qingxuan achieved revenue of CNY 1.052 billion, a year-on-year increase of 98% [2] - Gross profit reached CNY 866 million, reflecting a 99.5% year-on-year growth, while net profit surged to CNY 182 million, up 110.16% year-on-year [2] Group 3: Market Position and Innovation - According to Zhaoshang Consulting, Lin Qingxuan ranks first among high-end domestic skincare brands in China by retail sales in 2024, being the only domestic brand in the top 15 high-end skincare brands [3] - The company has increased its R&D investment, resulting in over 600 formula achievements and 87 patents, including 46 invention patents [3] Group 4: Strategic Initiatives - The release of the "Three-Year Action Plan for the Improvement of Quality Management System in Cosmetic Enterprises (2026-2028)" aligns with Lin Qingxuan's strategic development of high-altitude Camellia flower bases in Zhejiang and Jiangxi, creating a competitive barrier [3] - The founder, Sun Laichun, indicated plans to enhance R&D in skin science, botany, and cutting-edge skincare technologies, while also optimizing key products for better consumer experience and shareholder value [3]

Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, 2023, marking its position as the first high-end domestic skincare brand in the Hong Kong market [1][2]. Company Overview - Lin Qingxuan, founded in 2003, is known for its "oil-based skincare" approach, with its Camellia Oil Essence being a core product since its launch in 2014 [1]. - The company has expanded its brand portfolio to include Xiaoxin Xuan and Huai Piao Zhuang, targeting younger consumers and community beauty services respectively [1]. Financial Performance - For the first half of 2025, Lin Qingxuan reported revenue of 1.052 billion yuan, a significant increase of 98% year-on-year; gross profit reached 866 million yuan, up 99.5%; and net profit was 182 million yuan, reflecting a 110.16% increase [1]. - The company has achieved cumulative sales of over 50 million bottles of its Camellia Oil Essence, which has been the top-selling facial oil product in China for 11 consecutive years [2]. Market Position - Lin Qingxuan ranks first among high-end domestic skincare brands in China with a market share of 1.4%, and is the only domestic brand among the top 15 high-end skincare brands [3]. - The high-end skincare market in China is projected to reach 114.4 billion yuan in 2024, with the anti-wrinkle cosmetics market expected to grow to 260.24 billion yuan, accounting for 33.59% of the total cosmetics market [3]. Innovation and R&D - The company has over 600 formula achievements and 87 patents, including 46 invention patents, focusing on key areas such as Camellia ingredient extraction and anti-wrinkle technology [2]. - Lin Qingxuan has been recognized as a leading brand in "cell-level anti-wrinkle" technology, confirming its market position through a collaborative project with the Beauty Industry Research Institute [3]. Strategic Direction - The listing is seen as a new starting point for Lin Qingxuan to enhance its multi-brand and global expansion strategy, which will require improved supply chain capabilities and brand management [5]. - The company aims to strengthen its brand building and retail store layout while continuing to invest in research and development in skincare technology [2][5].

Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, becoming the first high-end domestic skincare stock in the Hong Kong market, showcasing the strength and confidence of domestic brands on the international stage [1] Group 1: Company Overview - Lin Qingxuan focuses on anti-wrinkle and firming skincare products, providing high-end solutions with natural camellia ingredients [1] - The company has established a strong professional recognition in the "oil-based skincare" sector, ranking first among domestic high-end skincare brands and being the only domestic representative among the top 15 high-end skincare brands in China [3] - The brand has achieved over 50 million sales of its camellia oil facial essence, maintaining the top position in the market for 11 consecutive years [3] Group 2: Product Development - The fifth generation of the camellia anti-wrinkle essence oil has been launched, featuring comprehensive iterations in efficacy verification, core ingredient ratios, and packaging [5] - The company has expanded its product matrix with several recognized products, including black gold cream 2.0 and high SPF sunscreen [6] - Lin Qingxuan controls the entire value chain from seedling cultivation to sales, ensuring product quality and stable supply [6] Group 3: Research and Innovation - The company has over 600 formula achievements and 87 patents, with 46 being invention patents, focusing on key areas like camellia extraction and anti-wrinkle technology [7] - A joint research laboratory with Shanghai Jiao Tong University will be established to explore anti-wrinkle mechanisms at the cellular level, aiming to integrate natural plant activity with modern life sciences [7] Group 4: Financial Performance - From 2022 to 2024, the company's revenue grew from 690 million to 1.21 billion, with a compound annual growth rate of 32.3%, significantly above the industry average [9] - In the first half of 2025, revenue surged by 98.3% to 1.05 billion compared to the same period in 2024, with adjusted net profit increasing by 117.4% [9] - The company aims to leverage its listing as a new starting point to further develop core technologies and expand its product matrix [9]

Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, with a share price of HKD 88, representing a rise of over 13.15%, and a total market capitalization of approximately HKD 12.29 billion [1] Group 1: Company Performance - Lin Qingxuan focuses on the anti-wrinkle and firming skincare industry, providing high-end skincare solutions with natural camellia ingredients [1] - Revenue is projected to grow from CNY 691 million in 2022 to CNY 1.21 billion in 2024, reflecting a compound annual growth rate (CAGR) of 32.3% [1] - In the first half of 2025, revenue is expected to increase by 98.3% to CNY 1.05 billion compared to CNY 530 million in the same period of 2024; adjusted net profit is anticipated to rise from CNY 92 million to CNY 200 million, a year-on-year increase of 117.4% [1] Group 2: Future Strategy - The founder, Sun Laichun, stated the company will continue to invest in research and development in dermatology, botany, and cutting-edge skincare technology [1] - There will be an emphasis on brand building and retail store expansion, alongside upgrading popular products such as camellia oil, golden pearl essence, and black gold cream to enhance customer skincare experiences and create higher value for shareholders [1]

Core Viewpoint - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, marking the emergence of the "first domestic high-end skincare stock" and signifying a pivotal moment in the high-end skincare industry, traditionally dominated by international giants [1][4]. Group 1: Company Growth and Product Strategy - The listing is seen as a new starting point for Lin Qingxuan's growth, with a clearer path to becoming a leading beauty brand [4]. - The cornerstone of Lin Qingxuan's success is its signature Camellia Oil, which has established a strong market presence and is expected to drive long-term growth [5]. - According to Zhi Zhi Consulting, Lin Qingxuan is the only domestic brand among the top 15 high-end skincare brands in China by retail sales in 2024, ranking first among all domestic high-end skincare brands [5]. - The Camellia Oil has maintained its position as the best-selling facial oil in China for 11 consecutive years, with cumulative sales exceeding 45 million bottles by June 30, 2025 [5][6]. - The introduction of the new 5.0 Camellia Anti-Wrinkle Repair Oil is expected to enhance the product's performance and contribute to overall revenue growth, with the oil category's revenue contribution projected to rise to 45.5% in the first half of 2025 [7]. Group 2: Future Growth Strategies - Lin Qingxuan aims to expand its product matrix with a focus on "cell-level anti-wrinkle" products to meet diverse skincare needs, including the upcoming "Cell Energy Black Gold Cream 2.0" [8]. - The company is also developing a multi-brand strategy, launching the "Xiaoxin Xuan" brand for consumers with sensitive skin and a community beauty service brand "Huaiqizhuang" to provide accessible personal care services [8]. - Lin Qingxuan has initiated its global expansion through the Southeast Asian market and cross-border e-commerce, creating new market opportunities [9]. - The partnership with global beauty giant L'Oréal is expected to enhance Lin Qingxuan's growth strategies by providing access to top-tier research resources and procurement systems, potentially accelerating the development of its Camellia-based products [10][11].